Neurobiology of Disease Three-Amino Acid Spacing of Presenilin Endoproteolysis Suggests a General Stepwise Cleavage of -Secretase-Mediated Intramembrane Proteolysis

Presenilin (PS1 or PS2) is the catalytic component of the -secretase complex, which mediates the final proteolytic processing step leading to the Alzheimer’s disease (AD)-characterizing amyloid -peptide. PS is cleaved during complex assembly into its characteristic Nand C-terminal fragments. Both fragments are integral components of physiologically active -secretase and harbor the two critical aspartyl residues of the active site domain. While the minimal subunit composition of -secretase has been defined and numerous substrates were identified, the cellular mechanism of the endoproteolytic cleavage of PS is still unclear. We addressed this pivotal question by investigating whether familial AD (FAD)-associated PS1 mutations affect the precision of PS endoproteolysis in a manner similar to the way that such mutations shift the intramembrane cleavage of -secretase substrates. We demonstrate that all FAD mutations investigated still allow endoproteolysis to occur. However, the precision of PS1 endoproteolysis is affected by PS1 mutations. Comparing the cleavage products generated by a variety of PS1 mutants revealed that specifically cleavages at positions 293 and 296 of PS1 are selectively affected. Systematic mutagenesis around the cleavage sites revealed a stepwise three amino acid spaced cleavage mechanism of PS endoproteolysis reminiscent to the -, -, and -cleavages described for typical -secretase substrates, such as the -amyloid precursor protein. Our findings therefore suggest that intramembranous cleavage by -secretase and related intramembrane-cleaving proteases may generally occur via stepwise endoproteolysis.